Frontlight ResearchEarly access
Trial site
MVZ für Hämatologie und Onkologie Ravensburg GmbH
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Lung cancer1 trial
- Multiple myeloma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Lead sponsor
- GBG Forschungs GmbH1 trial
- Nikolaj Frost MD1 trial
- Wuerzburg University Hospital1 trial
Running trials
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
Site data: ClinicalTrials.govUpdated 12 Nov 2026